Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CSCIF

COSCIENS Biopharma Inc.

USD

Set alert

Price alert · CSCIF

All alert types
6.10 USD -0.34 -5.28%
As of Oct 30, 2026
6.43 Day range 6.44
0.79 52-week range 9.50
YTD
+196.12%
1 year
+137.35%
Open
6.43
Prev close
6.44
Mkt cap
6.08M
Vol
1.00K
Avg vol
353
EPS
-4.12
P/E
0.00
More statistics
Low
6.43
High
6.44

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CSCIF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.66 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -0.2×
FY 2016: 11.4×FY 2017: -17.6×FY 2018: -38.9×FY 2019: -9.5×FY 2020: 11.4×FY 2021: 6.4×FY 2022: 3.6×FY 2023: -1.6×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025
P/S 0.3×
FY 2016: 3.8×FY 2017: 1.3×FY 2018: 1.1×FY 2019: 0.8×FY 2020: 3.8×FY 2021: 2.4×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.8× FY 2025
P/B 0.6×
FY 2016: 2.3×FY 2017: 0.8×FY 2018: 0.5×FY 2019: 0.5×FY 2020: 1.1×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.6×
FY 2016 5y median 0.3× FY 2025
P/FCF -0.2×
FY 2016: -544×FY 2017: -6.9×FY 2018: -3.7×FY 2019: -0.8×FY 2020: -3.2×FY 2021: -1.4×FY 2022: -1.3×FY 2023: -1.7×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -1.3× FY 2025
EV/EBITDA 0.3×
FY 2016: 7.9×FY 2017: -336×FY 2018: 0.6×FY 2019: 13.7×FY 2020: -4.3×FY 2021: -1.1×FY 2022: 1.4×FY 2023: 0.4×FY 2024: 0.9×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
EV/Sales -0.4×
FY 2016: 3.3×FY 2017: 1.0×FY 2018: 1.0×FY 2019: 1.0×FY 2020: -2.8×FY 2021: 1.8×FY 2022: 0.6×FY 2023: -0.1×FY 2024: -0.8×FY 2025: -0.4×
FY 2016 5y median -0.1× FY 2025
FCF Yield -429.4%
FY 2016: -0.2%FY 2017: -14.4%FY 2018: -27.3%FY 2019: -131.5%FY 2020: -31.3%FY 2021: -69.2%FY 2022: -77.7%FY 2023: -57.9%FY 2024: -659.9%FY 2025: -429.4%
FY 2016 5y median -77.7% FY 2025

Profitability

Gross Margin 35.3%
FY 2016: 68.4%FY 2017: 56.3%FY 2018: 52.9%FY 2019: 42.3%FY 2020: 128.6%FY 2021: 98.3%FY 2022: 58.7%FY 2023: 41.1%FY 2024: 49.3%FY 2025: 35.3%
FY 2016 5y median 49.3% FY 2025
Operating Margin -139.3%
FY 2016: 43.9%FY 2017: 20.6%FY 2018: 1.1%FY 2019: -4.6%FY 2020: -174.6%FY 2021: -164.8%FY 2022: 29.6%FY 2023: -64.8%FY 2024: -101.7%FY 2025: -139.3%
FY 2016 5y median -101.7% FY 2025
Net Margin -138.1%
FY 2016: 26.5%FY 2017: -7.4%FY 2018: -2.7%FY 2019: -8.8%FY 2020: 31.3%FY 2021: 39.7%FY 2022: 23.7%FY 2023: -48.8%FY 2024: -111.1%FY 2025: -138.1%
FY 2016 5y median -48.8% FY 2025
ROE -274.8%
FY 2016: 16.2%FY 2017: -4.3%FY 2018: -1.4%FY 2019: -5.1%FY 2020: 8.7%FY 2021: 3.9%FY 2022: 7.1%FY 2023: -16.6%FY 2024: -116.3%FY 2025: -274.8%
FY 2016 5y median -16.6% FY 2025
ROIC -58.3%
FY 2016: 16.2%FY 2017: 10.8%FY 2018: 0.2%FY 2019: -2.3%FY 2020: -36.8%FY 2021: -10.7%FY 2022: 17.7%FY 2023: -16.0%FY 2024: -49.9%FY 2025: -58.3%
FY 2016 5y median -16.0% FY 2025
ROA -49.3%
FY 2016: 13.7%FY 2017: -3.4%FY 2018: -1.2%FY 2019: -4.2%FY 2020: 3.1%FY 2021: 2.6%FY 2022: 4.6%FY 2023: -14.7%FY 2024: -43.7%FY 2025: -49.3%
FY 2016 5y median -14.7% FY 2025

Growth (YoY)

Revenue -44.7%
FY 2016: 32.3%FY 2017: 1.0%FY 2018: -17.2%FY 2019: 15.8%FY 2020: -52.9%FY 2021: 43.1%FY 2022: 119.1%FY 2023: -51.0%FY 2024: 93.0%FY 2025: -44.7%
FY 2016 FY 2025
Operating Income 24.3%
FY 2016: 70.6%FY 2017: -52.7%FY 2018: -95.5%FY 2019: -577.6%FY 2020: -1707.1%FY 2021: -35.1%FY 2022: 139.4%FY 2023: -207.2%FY 2024: -202.9%FY 2025: 24.3%
FY 2016 FY 2025
EPS (diluted) 43.8%
FY 2016: -37.0%FY 2017: -120.2%FY 2018: 69.8%FY 2019: -269.2%FY 2020: 277.1%FY 2021: 56.5%FY 2022: 39.8%FY 2023: -201.6%FY 2024: -213.8%FY 2025: 43.8%
FY 2016 FY 2025
Free Cash Flow 40.7%
FY 2016: 55.6%FY 2017: -2622.4%FY 2018: -27.5%FY 2019: -342.6%FY 2020: 49.4%FY 2021: -96.0%FY 2022: -20.9%FY 2023: 74.9%FY 2024: -376.1%FY 2025: 40.7%
FY 2016 FY 2025

Financial Health

Current Ratio 3.2×
FY 2016: 4.5×FY 2017: 2.2×FY 2018: 4.5×FY 2019: 3.7×FY 2020: 6.5×FY 2021: 394×FY 2022: 1.6×FY 2023: 8.6×FY 2024: 3.3×FY 2025: 3.2×
FY 2016 5y median 3.3× FY 2025
Quick Ratio 2.8×
FY 2016: 4.0×FY 2017: 1.9×FY 2018: 4.0×FY 2019: 3.3×FY 2020: 5.6×FY 2021: 386×FY 2022: 1.3×FY 2023: 5.5×FY 2024: 2.9×FY 2025: 2.8×
FY 2016 5y median 2.9× FY 2025
Debt / Equity 0.6×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.6×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: -1.1×FY 2017: 127×FY 2018: -0.1×FY 2019: 1.6×FY 2020: -10.1×FY 2021: 0.4×FY 2022: -1.3×FY 2023: 2.8×FY 2024: 1.0×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -62.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.7×FY 2020: -10.5×FY 2021: -527×FY 2022: 30.2×FY 2023: -34.0×FY 2024: -109×FY 2025: -62.1×
FY 2016 5y median -62.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31